Key result
A male patient with the BAG3 (Pro209Leu) mutation presented with severe progressive muscle weakness but lacked evident cardiomyopathy by age 19, highlighting a wide phenotypic spectrum.
Case Report (n=1)
This case demonstrates that the BAG3 (Pro209Leu) mutation, typically associated with rapidly progressive childhood cardiomyopathy, can present without cardiac involvement up to age 19, expanding the known phenotypic spectrum.
Answers are grounded in this paper and cite their sources.
BAG3 Pro209Leu may show incomplete cardiac penetrance; leaves open expanded phenotypic spectrum and need for prospective genotype-phenotype studies.
Myofibrillar myopathy is a clinically and genetically heterogeneous group of muscle disorders characterized by myofibrillar degeneration. Bcl-2-associated athanogene 3 (BAG3)-related myopathy is the rarest form of myofibrillar myopathy. Patients with BAG3-related myopathy present with early-onset and progressive muscle weakness, rigid spine, respiratory insufficiency, and cardiomyopathy. Notably, the heterozygous mutation (Pro209Leu) in BAG3 is commonly associated with rapidly progressive cardiomyopathy in childhood. We describe a male patient with the BAG3 (Pro209Leu) mutation. The patient presented at age 7 years with muscle weakness predominantly in the proximal lower limbs. Histologic findings revealed a mixture of severe neurogenic and myogenic changes. His motor symptoms progressed rapidly in the next decade, becoming wheelchair-dependent by age 17 years; however, at the age of 19 years, cardiomyopathy was not evident. This study reports a case of BAG3-related myopathy without cardiac involvement and further confirmed the wide phenotypic spectrum of BAG3-related myopathy.
No takes yet. Share an insight, caveat, or question.
Akaba et al. (2022) conducted a case report in BAG3-related myopathy (n=1). BAG3 (Pro209Leu) mutation was evaluated on Cardiac involvement / cardiomyopathy. A male patient with the BAG3 (Pro209Leu) mutation presented with severe progressive muscle weakness but lacked evident cardiomyopathy by age 19, highlighting a wide phenotypic spectrum.
Synapse has enriched 10 related papers. Consider them for comparative context: